Better Big Pharma Stock: AbbVie vs. AstraZeneca - Motley Fool

Better Big Pharma Stock: AbbVie vs. AstraZeneca  Motley Fool

These A-list drugmakers must both contend with expiring patents, new drug uncertainties, and hungry competitors. But they're in different stages of their cyclical ...